UNII IY9XDZ35W2

DEXTROSE, UNSPECIFIED FORM

Unique Ingredient Identifier IY9XDZ35W2 is listed as a unspecified ingredient
UniiIY9XDZ35W2
Preferred Substance NameDEXTROSE, UNSPECIFIED FORM
NcitC2831
Rxcui4850
Unii TypeUNSPECIFIED INGREDIENT
NCITC2831
RXCUI4850

Alternate Names

Dosage Forms

UNII IY9XDZ35W2 DEXTROSE, UNSPECIFIED FORM is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,CNBLK INTRATHECALINJECTION7.5 %
IM - IVINJECTION5 %
IM - IV - SCINJECTION NA
INTERSTITIALINJECTION NA
INTRACAVITARYINJECTION NA
INTRAMUSCULARINJECTION4.4 %W/V
INTRAPERITONEALINJECTION NA
INTRAPLEURALINJECTION NA
INTRASPINALINJECTION5 %
INTRAVENOUSINJECTABLE5 %
INTRAVENOUSINJECTION NA
INTRAVENOUSINJECTION, SOLUTION5 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION5.02 %
INTRAVENOUSSOLUTION0.05 %
INTRAVENOUSSOLUTION, INJECTION5 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION5 %
NASALSPRAY5300 UG/SPRAY
NASALSPRAY5 MG/SPR
NASALSPRAY, METERED5 %
ORALCAPSULE, DELAYED ACTION1.1 MG
ORALCONCENTRATE40 MG/ML
ORALGRANULE, FOR ORAL SUSPENSION2813 MG
ORALLIQUID160 MG/4ML
ORALPASTILLE826 MG
ORALPELLET2813 MG
ORALPOWDER, FOR SOLUTION NA
ORALSOLUTION2489 MG/5ML
ORALSOLUTION, ELIXIR NA
ORALSUSPENSION500 MG/5ML
ORALSYRUP1350 MG/5ML
ORALTABLET183.66 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE398 MG
ORALTABLET, EXTENDED RELEASE103.95 MG
ORALTABLET, ORALLY DISINTEGRATING1.2 MG
ORALTABLET, SUSTAINED ACTION2 MG
ORALTABLET, UNCOATED, TROCHE903.5 MG
SPINALINJECTION7.5 %
SUBLINGUALTABLET115.78 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.